PodcastIntel
Sign in Get Started Free
Citeline Podcasts
Citeline Podcasts

Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO

Sep 27, 2024 · 37m
Listen to Episode
✨ AI Summary
  • Pfizer withdraws sickle cell drug Oxbryta.
  • FDA's ODAC re-evaluates approved drug labeling.
  • New CEO appointed for generic industry trade association.

More from Citeline Podcasts

Citeline Podcasts
Scrip's Five Must-Know Things - Oct. 13, 2026
Oct 13, 2026 · 16m
Citeline Podcasts
Strategic Intent: Celebrity Marketing In The Age Of Promo Crackdown
Oct 13, 2026 · 26m
Citeline Podcasts
Drug Fix: US FDA’s Peptide Drama, More Transparency, Ibogaine Clinical Trial Plans
Oct 9, 2026 · 41m
Citeline Podcasts
Off-Patent, On Record: Navigating The Financial Strategy Behind Litigation With Sandoz’s Julia Pike
Oct 6, 2026 · 24m
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Citeline Podcasts and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →